Document:

Exhibit

Exhibit 4.1

This Note is registered in the name of The Depository Trust Company (the “Depositary”) (55 Water Street, New York, New York) or its nominee, and this Note may not be transferred except as a whole by the Depositary to a nominee of the Depositary or by a nominee of the Depositary to the Depositary or another nominee of the Depositary or by the Depositary or any such nominee to a successor Depositary or a nominee of such successor Depositary unless and until this Note is exchanged in whole or in part for Notes in definitive form. Unless this certificate is presented by an authorized representative of the Depositary to the Company or its agent for registration of transfer, exchange or payment, and any certificate issued is registered in the name of Cede & Co. or such other name as requested by an authorized representative of the Depositary and any payment is made to Cede & Co., or such other name ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL since the registered owner hereof, Cede & Co, has an interest herein.

No. R-1                                           $300,000,000 
 
CUSIP: 059165 EJ5                

BALTIMORE GAS AND ELECTRIC COMPANY

3.750% Note due 2047

PRINCIPAL AMOUNT: $300,000,000  
INTEREST RATE:     3.750% per annum 
STATED MATURITY: August 15, 2047
ORIGINAL ISSUE DATE:  August 24, 2017

ISSUE PRICE:  99.199%

Baltimore Gas and Electric Company, a Maryland corporation (herein called the “Company”, which term includes any successor corporation under the Indenture, as hereinafter defined), for value received, promises to pay to Cede & Co. or its registered assigns, the principal sum of $300,000,000 (THREE HUNDRED MILLION DOLLARS) on the Stated Maturity shown above and to pay interest on said principal sum from August 24, 2017, at the fixed rate per annum shown above, semi-annually on February 15 and August 15 (the “Interest Payment Dates”) of each year beginning February 15, 2018 until the Stated Maturity or upon redemption of this Note.  Each payment of interest payable on each Interest Payment Date and at Stated Maturity or, if applicable, upon redemption shall include interest to, but excluding the relevant Interest Payment Date and the date of Stated Maturity or redemption, respectively. Said interest shall be computed on the basis of a 360-day year of twelve 30-day months. In the event this Note is issued between a Record Date (which shall be the close of business on the first calendar day immediately preceding such Interest Payment Date, provided that if the Notes are held by a securities depository in book-entry form, the Record Date will be the close of business on the Business Day immediately preceding such Interest Payment Date) and an Interest Payment Date or on an Interest Payment Date, the first day that interest shall be payable will be on the Interest Payment Date following the next succeeding Record Date.  If any Interest Payment Date falls on a day that is not a Business Day, 

payment will be made on the next Business Day and no additional interest or other payment will be paid in respect of such delay. In the event of a Default in the payment of interest, interest will be payable as provided in that certain Indenture dated as of July 24, 2006 (the “Indenture”), between the Company and Deutsche Bank Trust Company Americas, a corporation duly organized and existing under the laws of the State of New York, as Trustee (herein called the “Trustee,” which term includes any successor Trustee under the Indenture).

At any time prior to February 15, 2047 (six months prior to the Stated Maturity of the Notes), the Company may redeem some or all of the Notes, upon at least 10 days’ and not more than 60 days’ notice, at its option, at a redemption price equal to the greater of:

•100% of the principal amount of the Notes then Outstanding to be redeemed; and

•the sum of the present values of the remaining scheduled payments of principal and interest on the Notes (exclusive of interest accrued to the redemption date) being redeemed, discounted to the redemption date on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate plus 15 basis points;

At any time on or after February 15, 2047, the Company may redeem some or all of the Notes, upon at least 10 days’ and not more than 60 days’ notice, at its option, at a redemption price equal to 100% of the principal amount of the Notes then Outstanding to be redeemed plus accrued and unpaid interest on the principal amount being redeemed to the redemption date.

If at the time a redemption notice is given, the redemption moneys are not on deposit with the Trustee, then the redemption shall be subject to their receipt on or before the redemption date and such notice shall be of no effect unless such moneys are so received. Any redemption may be conditioned upon the consummation of one or more other transactions, including any debt or equity issuance by us or any of our parent companies.

As used in this Note:

“Comparable Treasury Issue” means the United States Treasury security or securities selected by an Independent Investment Banker as having an actual or interpolated maturity comparable to the remaining term of the Notes being redeemed that would be utilized, at the time of selection and in accordance with customary financial practice, in pricing new issues of corporate debt securities of a comparable maturity to the remaining term of the Notes.

“Comparable Treasury Price” means, with respect to any redemption date, the average of the Reference Treasury Dealer Quotations for such redemption date.

“Independent Investment Banker” means one of the Reference Treasury Dealers appointed by the Company.

“Reference Treasury Dealer” means (i) any of J.P. Morgan Securities LLC, Credit Suisse Securities (USA) LLC, Morgan Stanley & Co. LLC, and a Primary Treasury Dealer (as defined below) selected by Credit Agricole Securities (USA) Inc., and in each case their respective successors and affiliates and (ii) one other primary U.S. Government securities dealer in the United States of America (each, a “Primary Treasury Dealer”) selected by the Company; provided, however, that if any of the foregoing shall cease to be a Primary Treasury Dealer, or is unwilling or unable to serve in such role, the Company shall substitute therefor another Primary Treasury Dealer.

2

“Reference Treasury Dealer Quotations” means, with respect to each Reference Treasury Dealer and any redemption date, the average, as determined by the Company, of the bid and asked prices for the Comparable Treasury Issue (expressed in each case as a percentage of its principal amount) quoted in writing to the Company at 3:30 p.m. New York City time on the third Business Day preceding such redemption date.

“Treasury Rate” means, with respect to any redemption date, the rate per annum equal to the semi-annual equivalent yield to actual or interpolated maturity (on a day count basis) of the Comparable Treasury Issue, assuming a price for the Comparable Treasury Issue (expressed as a percentage of its principal amount) equal to the Comparable Treasury Price for such redemption date.

Pursuant to the provisions of the Indenture, the Company will maintain an agency at Deutsche Bank Trust Company Americas in the City of New York, New York (the “Bank”), or at such other agencies as may from time to time be designated, where the Notes may be presented for payment, for registration of transfer and exchange, and where notices or demands to, or upon, the Company may be served.

The interest so payable on any Interest Payment Date will, subject to certain exceptions provided in the Indenture, be paid to the person in whose name this Note is registered at the close of business on the Record Date for such Interest Payment Date; provided, however, that interest payable at Stated Maturity or, if applicable, upon redemption, shall be payable to the person to whom principal shall be payable. Payment of the principal of and interest on this Note will be made at the Bank in U.S. dollars; provided, however, that payments of interest (other than any interest payable at Stated Maturity or upon redemption) may be made at the option of the Company (i) by checks mailed to the addresses of the persons entitled thereto as such addresses shall appear in the register of the Notes or (ii) by wire transfer to persons who are holders of record at such other addresses that have been filed with the Bank on or prior to the Record Date.

Payment of the principal, premium, if any, and interest payable at Stated Maturity, or, if applicable, upon redemption, on this Note will be made in immediately available funds at the request of the holder provided that this Note is presented to the Bank in time for the Bank to make such payments in such funds in accordance with its normal procedures.

Reference is made to the further provisions of this Note set forth on the reverse hereof, which shall have the same effect as though fully set forth at this place.

Unless the certificate of authentication hereon has been executed by or on behalf of the Trustee or a duly designated authentication agent by manual signature, this Note shall not be entitled to any benefit under said Indenture, or be valid or obligatory for any purpose.

IN WITNESS WHEREOF, Baltimore Gas and Electric Company has caused this instrument to be executed in its corporate name with the manual or facsimile signature of its President or a Vice President and a facsimile of its corporate seal to be imprinted hereon, attested by the manual or facsimile signature of its Secretary or an Assistant Secretary.

3

BALTIMORE GAS AND ELECTRIC COMPANY

By:                                                                               
Name:     David M. Vahos
Title:     Senior Vice President, Chief Financial
Officer and Treasurer

ATTEST:

By:                                                                               
Name:     Brian Buck
Title:     Assistant Secretary

[SEAL]

Dated: August 24, 2017

4

CERTIFICATE OF AUTHENTICATION

This is one of the Securities of the series designated herein issued under the Indenture described herein.

DEUTSCHE BANK TRUST COMPANY AMERICAS,
as Trustee under the Indenture

By: ___________________________   
      Authorized Signatory

Dated: August 24, 2017    

5

(REVERSE)

BALTIMORE GAS AND ELECTRIC COMPANY      3.750% NOTE DUE AUGUST 15, 2047
This Note is one of a duly authorized issue of debt securities (the “Securities”) of the Company, of a series designated as its 3.750% Notes due August 15, 2047 (herein called the “Notes”), issued and to be issued under the Indenture, to which Indenture and all relevant indentures supplemental thereto reference is hereby made for a statement of the respective rights, obligations, duties and immunities thereunder of the Company, the Trustee, the Bank and the Securityholders and the terms upon which the Notes are, and are to be, authenticated and delivered.  The Securities, of which the Notes constitute a series, may be issued in one or more series, which different series may be issued in various aggregate principal amounts, may mature at different times, may bear interest at different rates, may be subject to different covenants and Events of Default and may otherwise vary as provided in the Indenture. All capitalized terms not otherwise defined herein shall have the definitions assigned to them in the Indenture.

The Company is not required to repurchase Notes from holders prior to Stated Maturity. 

In the event of redemption of this Note in part only, a new Note or Notes of this series, having the same Stated Maturity, optional redemption provisions, Interest Rate and other terms and provisions of this Note, in authorized denominations in an aggregate principal amount equal to the unredeemed portion hereof will be issued in the name of the holder hereof upon the surrender hereof.

The Notes will not be subject to conversion, amortization or any sinking fund.

As provided in the Indenture and subject to certain limitations herein and therein set forth, the transfer of this Note may be registered on the register of the Notes, upon surrender of this Note for registration of transfer at the Bank, or at such other agencies as may be designated pursuant to the Indenture, duly endorsed by, or accompanied by a written instrument of transfer in form satisfactory to the Trustee or the Bank duly executed by, the holder hereof or his attorney duly authorized in writing, and thereupon one or more new Notes, of authorized denominations and for the same aggregate principal amount, will be issued to the designated transferee or transferees.

The Notes are issuable as registered Notes in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof.  As provided in the Indenture, and subject to certain limitations herein and therein set forth, the Notes are exchangeable for a like aggregate principal amount of Notes of other authorized denominations having the same interest rate, Stated Maturity, optional redemption provisions, if any, and Original Issue Date, as requested by the Security holder surrendering the same.

No service charge will be made for any such registration of transfer or exchange, but the Company may require payment of a sum sufficient to cover any tax or other governmental charge payable in connection therewith.
The Company, the Trustee, the Bank, the Security registrar and any agent of the Company, the Trustee, the Bank, or the Security registrar may treat the Security holder in whose name this Note is registered as the absolute owner hereof for the purpose of receiving payment as herein provided and for all other purposes, whether or not this Note is overdue, and neither the Company, the Trustee, the Bank, the Security registrar nor any such agent shall be affected by notice to the contrary.

If an Event of Default (as defined in the Indenture) with respect to the Notes shall occur and be 

6

continuing, the principal of all the Notes may be declared due and payable in the manner and with the effect provided in the Indenture.

The Indenture permits, with certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations of the Company and the rights of the holders of the Securities of any series under the Indenture at any time by the Company with the consent of the holders of not less than 66 2/3% in aggregate principal amount of the Securities at the time Outstanding to be affected (voting as one class). The Indenture also permits the Company and the Trustee to enter into supplemental indentures without the consent of the holders of Securities of any series for certain purposes specified in the Indenture, including the making of such other provisions in regard to matters arising under the Indenture which shall not adversely affect the interest of the holders of such Securities. The Indenture also contains provisions permitting the holders of specified percentages in aggregate principal amount of the Securities of any series at the time Outstanding, on behalf of the holders of all the Securities of such series, to waive compliance by the Company with certain provisions of the Indenture and certain past Defaults under the Indenture and their consequences. Any such consent or waiver by the holder of this Note shall be conclusive and binding upon such holder and upon all future holders of this Note and of any Note issued upon the registration of transfer hereof or in exchange herefor or in lieu hereof whether or not notation of such consent or waiver is made upon this Note.

The Indenture provides that no holder of any Security of any series may enforce any remedy with respect to such series under the Indenture except in the case of refusal or neglect of the Trustee to act after notice of a continuing Event of Default and after written request by the holders of not less than 25% in aggregate principal amount of the Outstanding Securities of such series and the offer to the Trustee of reasonable indemnity; provided, however, that such provision shall not prevent the holder hereof from enforcing payment of the principal of or interest on this Note.

No reference herein to the Indenture and no provision of this Note or of the Indenture shall alter or impair the obligation of the Company, which is absolute and unconditional, to pay the principal of and interest on this Note at the times, place and rate, and in the coin or currency, herein prescribed.

No recourse shall be had for the payment of the principal of or the interest on this Note, or for any claim based hereon, or otherwise in respect hereof, or based on or in respect of the Indenture or any indenture supplemental thereto, against any incorporator, stockholder, officer or director, as such, past, present or future, of the Company or any predecessor or successor corporation, whether by virtue of any constitution, statute or rule of law, or by the enforcement of any assessment or penalty or otherwise, all such liability being, by the acceptance hereof and as part of the consideration for the issue hereof, expressly waived and released. This Note shall be governed by and construed in accordance with the laws of the State of New York.

7

ASSIGNMENT FORM

To assign this Note, fill in the form below:

Assignee’s Social Security or Tax I.D. Number:      

FOR VALUE RECEIVED, the undersigned hereby sells, assigns and transfers unto

(Print or Type Assignee’s Name, Address and Zip Code)

the within Note of the Company and hereby does irrevocably constitute and appoint

Attorney to transfer the said Note on the books of the Company, with full power of substitution in the premises.

Signature of Assignor
(Sign exactly as name appears on the face of the Note)

 Dated:      

8

SIGNATURE GUARANTEE

Signatures must be guaranteed by an ‘‘eligible guarantor institution” meeting the requirements of the Trustee, which requirements include membership or participation in the Security Transfer Agent Medallion Program (“STAMP”) or such other “signature guarantee program” as may be determined by the Trustee in addition to, or in substitution for, STAMP, all in accordance with the Securities Exchange Act of 1934, as amended.

9Exhibit
10.1

 

SHARE
EXCHANGE AGREEMENT

 

This
SHARE EXCHANGE AGREEMENT, dated as of July 19, 2017 (the “Agreement”) by and among TraqIQ, Inc., a California
corporation (“TRAQIQ”), on the one hand, and OmniM2M, Inc., a corporation incorporated under the laws of Washington
(“OmniM2M”), and the holders of ordinary common and preferred shares of OmniM2M, identified on Exhibit A
hereto (each an “OmniM2M Stockholder” and collectively the “OmniM2M Stockholders”) and Ci2i
Services, Inc., a corporation incorporated under the laws of Washington (“Ci2i”), and the holders of ordinary
common and preferred shares of Ci2i, identified on Exhibit B hereto (each an “Ci2i Stockholder” and collectively
the “Ci2i Stockholders”), on the other hand.

 

WHEREAS,
the OmniM2M Stockholders own 1,080,270, common shares, par value $0.00001, and 403,386 preferred shares, par value $0.00001, of
OmniM2M, constituting 100% of the issued and outstanding common and preferred shares, respectively of OmniM2M (the “OmniM2M
Shares”); and

 

WHEREAS,
subject to the terms and conditions of this Agreement, the OmniM2M Stockholders believe it is in their best interests to exchange
all of the OmniM2M Shares for an aggregate of 3,000,000 shares of common stock (“Common Stock”), par value $.0001
per share of TRAQIQ (the “TRAQIQ Omni Shares”) delivered on the Closing Date.

 

WHEREAS,
the Ci2i Stockholders own 15,162,561 common shares, no par value per share, and 1,494,042 preferred shares, no par value per share
of Ci2i, constituting 100% of the issued and outstanding common and preferred shares of Ci2i, respectively (the “Ci2i
Shares”); and

 

WHEREAS,
subject to the terms and conditions of this Agreement, the Ci2i Stockholders believe it is in their best interests to exchange
all of the Ci2i Shares for an aggregate of 3,000,000 shares of common stock (“Common Stock”), par value $.0001 per
share of TRAQIQ (the “TRAQIQ Ci2I Shares”) delivered on the Closing Date.

 

WHEREAS,
TRAQIQ believes it is in its best interests to acquire the OmniM2M Shares and the Ci2i Shares in exchange for TRAQIQ Omni Shares
and the TRAQIQ Ci2i Shares (collectively, the “TRAQIQ Shares”);

 

NOW,
THEREFORE, in consideration of the mutual terms, conditions and other agreements set forth herein, the parties hereto hereby agree
as follows:

 

ARTICLE
I 

EXCHANGE
OF SHARES

 

Section
1.1 Agreement to Exchange TRAQIQ Shares for OmniM2M Shares and the Ci2i Shares.

 

a.
On the Closing Date (as hereinafter defined) and upon the terms and subject to the conditions set forth in this Agreement, the
OmniM2M Stockholders shall sell, assign, transfer, convey and deliver to TRAQIQ the OmniM2M Shares set forth opposite their name
on Exhibit A hereto (representing 100% of the issued and outstanding common and preferred shares of OmniM2M), and TRAQIQ
shall accept such securities from the OmniM2M Stockholders in exchange for the issuance to the OmniM2M Stockholders of the TRAQIQ
Omni Shares; and

 

b.
On the Closing Date (as hereinafter defined) and upon the terms and subject to the conditions set forth in this Agreement, the
Ci2i Stockholders shall sell, assign, transfer, convey and deliver to TRAQIQ the Ci2i Shares set forth opposite their name on
Exhibit B hereto (representing 100% of the issued and outstanding common and preferred shares of Ci2i), and TRAQIQ shall
accept such securities from the Ci2i Stockholders in exchange for the issuance to the Ci2i Stockholders of the TRAQIQ Ci2i Shares
(both such transactions, the “Share Exchange Transaction”).

 

Section
1.2 Capitalization. On the Closing Date, immediately before the Share Exchange Transaction, TRAQIQ shall have authorized
300,000,000 shares of Common Stock, par value $0.0001 per share, of which 824,250 shares shall be issued and outstanding, all
of which are duly authorized, validly issued and fully paid.

 

    	1

    	 

    

 

Section
1.3 Closing. The closing of the Share Exchange Transaction (the “Closing”) shall take place at 5:00
p.m. P.D.T. on the business day after which each of the parties hereto has executed this Agreement, or at such other time and
date as the parties hereto shall agree in writing (the “Closing Date”). The OmniM2M Stockholders and the Ci2i
Stockholders shall deliver to TRAQIQ the following items: (a), within five (5) business days after the Closing, the original stock
certificates representing the OmniM2M Shares and the Ci2i Shares, duly endorsed in blank for transfer or accompanied by appropriate
stock powers duly executed in blank, and (b) within ten (10) business days after the Closing, a certificate of incumbency duly
recording the registered shareholders of OmniM2M and Ci2i to reflect the ownership of TRAQIQ as a result of the Share Exchange
Transaction. In full consideration for the OmniM2M Shares and the Ci2i Shares, TRAQIQ (i) shall issue the TRAQIQ Shares to the
OmniM2M Stockholders and the Ci2i Stockholders within ten (10) business days of the Closing Date in proportion to the number of
OmniM2M Shares exchanged by each OmniM2M Stockholder and the number of Ci2i Shares exchanged by each Ci2i Stockholders, as detailed
on Exhibit A and Exhibit B, respectively, attached hereto.

 

ARTICLE
II

REPRESENTATIONS
AND WARRANTIES OF TRAQIQ

 

TRAQIQ
hereby represents, warrants and agrees as follows:

 

Section
2.1 Corporate Organization

 

a.
TRAQIQ is a corporation duly organized, validly existing and in good standing under the laws of California, and has all requisite
corporate power and authority to own its properties and assets and to conduct its business as now conducted and is duly qualified
to do business in good standing in each jurisdiction in which the nature of the business conducted by TRAQIQ or the ownership
or leasing of its properties makes such qualification and being in good standing necessary, except where the failure to be so
qualified and in good standing will not have a material adverse effect on the business, operations, properties, assets, condition
or results of operation of TRAQIQ (a “TRAQIQ Material Adverse Effect”);

 

b.
Copies of the Articles of Incorporation and Bylaws of TRAQIQ, with all amendments thereto to the date hereof, have been furnished
to OmniM2M and Ci2i and the OmniM2M Stockholders and Ci2i Stockholders, and such copies are accurate and complete as of the date
hereof. The minute books of TRAQIQ are current as required by law, contain the minutes of all meetings of the Board of Directors
and shareholders of TRAQIQ from its date of incorporation to the date of this Agreement, and adequately reflect all material actions
taken by the Board of Directors and shareholders of TRAQIQ.

 

Section
2.2 Capitalization of TRAQIQ.

 

a.
The authorized capital stock of TRAQIQ immediate prior to the Closing Date consists of 300,000,000 shares of Common Stock, par
value $.0001 per share, of which 824,250 shares are issued and outstanding, all of which are duly authorized, validly issued and
fully paid and 10,000,000 shares of its Series A Preferred Stock, par value $0.0001 per share, 50,000 of which are duly authorized,
validly issued and fully paid. All of the TRAQIQ Shares to be issued on the Closing Date pursuant to this Agreement have been
duly authorized and will be validly issued, fully paid and non-assessable and no personal liability will attach to the ownership
thereof. As of the Closing Date, there are, no outstanding options, warrants, agreements, commitments, conversion rights, preemptive
rights or other rights to subscribe for, purchase or otherwise acquire any shares of capital stock or any un-issued shares of
capital stock of TRAQIQ other than as set forth herein.

 

Section
2.3 Authorization and Validity of Agreements. TRAQIQ has all corporate power and authority to execute and deliver
this Agreement, to perform its obligations hereunder and to consummate the transactions contemplated hereby. The execution and
delivery of this Agreement by TRAQIQ and the consummation by TRAQIQ of the transactions contemplated hereby have been duly authorized
by all necessary corporate action of TRAQIQ, and no other corporate proceedings on the part of TRAQIQ are necessary to authorize
this Agreement or to consummate the transactions contemplated hereby.

 

    	2

    	 

    

 

Section
2.4 No Conflict or Violation. The execution, delivery and performance of this Agreement by TRAQIQ does not and will
not violate or conflict with any provision of its Articles of Incorporation or Bylaws, as amended, and does not and will not violate
any provision of law, or any order, judgment or decree of any court or other governmental or regulatory authority, nor violate
or result in a breach of or constitute (with due notice or lapse of time or both) a default under, or give to any other entity
any right of termination, amendment, acceleration or cancellation of, any contract, lease, loan agreement, mortgage, security
agreement, trust indenture or other agreement or instrument to which TRAQIQ is a party or by which it is bound or to which any
of their respective properties or assets is subject, nor will it result in the creation or imposition of any lien, charge or encumbrance
of any kind whatsoever upon any of the properties or assets of TRAQIQ, nor will it result in the cancellation, modification, revocation
or suspension of any of the licenses, franchises, permits to which TRAQIQ is bound.

 

Section
2.5 Consents and Approvals. No consent, waiver, authorization or approval of any governmental or regulatory authority,
domestic or foreign, or of any other person, firm or corporation, is required in connection with the execution and delivery of
this Agreement by TRAQIQ or the performance by TRAQIQ of its obligations hereunder.

 

Section
2. Securities and Exchange Commission Reports. The Company has filed all forms, reports, statements and other documents
required to be filed with the Securities and Exchange Commission.

 

ARTICLE
III

REPRESENTATIONS
AND WARRANTIES OF OMNIM2M AND THE OMNIM2M STOCKHOLDERS

AND
CI2I AND CI2I STOCKHOLDERS

 

OmniM2M
and each OmniM2M Stockholder and Ci2i and each Ci2i Stockholder, jointly and severally, represent, warrant and agree as follows:

 

Section
3.1 Corporate Organization.

 

a.
OmniM2M and Ci2i are duly organized, validly existing and in good standing under the laws of the State of Washington and have
all requisite corporate power and authority to own their properties and assets and to conduct their business as now conducted
and are duly qualified to do business in good standing in each jurisdiction in where the nature of the business conducted by OmniM2M
or Ci2i or the ownership or leasing of their properties makes such qualification and being in good standing necessary, except
where the failure to be so qualified and in good standing will not have a material adverse effect on the business, operations,
properties, assets, condition or results of operation of OmniM2M or Ci2i (a “OmniM2M Material Adverse Effect”
or “Ci2i Material Adverse Effect”).

 

b.
Copies of the Articles of Incorporation of OmniM2M and Ci2i, with all amendments thereto to the date hereof, have been furnished
to TRAQIQ, and such copies are accurate and complete as of the date hereof. The minute books of OmniM2M and Ci2i are current as
required by law, contain the minutes of all meetings of the Board of Directors and Stockholder of OmniM2M and Ci2i, respectively,
and committees of the Board of Directors of OmniM2M and Ci2i from the date of incorporation to the date of this Agreement, and
adequately reflect all material actions taken by the Board of Directors, shareholders and committees of the Board of Directors
of OmniM2M and Ci2i.

 

Section
3.2 Capitalization of OmniM2M and Ci2i; Title to the OmniM2M Shares and Ci2i Shares.

 

a.
On the Closing Date, immediately before the transactions to be consummated pursuant to this Agreement, OmniM2M shall have authorized:
(i) 98,500,000 shares of common shares, par value $0.00001 per share, of which 1,080,270 shares are issued and outstanding; and
(ii) 1,500,000 shares of preferred stock, 403,386 and 395,549 shares/units issued and outstanding; and

 

b.
Ci2i shall have authorized: (i) 60,000,000 shares of common shares, no par value per share, of which 15,162,561common shares are
issued and outstanding; and (ii) 40,000,000 shares of preferred stock, no par value, of which 5,000,000 are authorized as a Series
A preferred, no par value, and of which 1,494,042 are issued and outstanding. There are no outstanding options, warrants, agreements,
commitments, conversion rights, preemptive rights or other rights to subscribe for, purchase or otherwise acquire any shares of
capital stock or any unissued or treasury shares of capital stock of OmniM2M or Ci2i. As of the date of this Agreement, the OmniM2M
Stockholders hold the OmniM2M Shares as set forth on Exhibit A, free of any lien or encumbrance and the Ci2i Stockholders
hold the Ci2i Shares as set forth on Exhibit B, free of any lien or encumbrance.

 

    	3

    	 

    

 

Section
3.3 Subsidiaries and Equity Investments; Assets. As of the date hereof and on the Closing Date, neither OmniM2M nor
Ci2i directly or indirectly, own any shares of capital stock or any other equity interest in any entity nor any right to acquire
any shares or other equity interest in any entity, and each of OmniM2M and Ci2i does not and will not have any assets or liabilities.

 

Section
3.4 Authorization and Validity of Agreements. OmniM2M and Ci2i have all corporate power and authority to execute and
deliver this Agreement, to perform their obligations hereunder and to consummate the transactions contemplated hereby. The execution
and delivery of this Agreement by OmniM2M and Ci2i and the consummation of the transactions contemplated hereby have been duly
authorized by all necessary corporate action and no other corporate proceedings on the part of OmniM2M or Ci2i are necessary to
authorize this Agreement or to consummate the transactions contemplated hereby. No OmniM2M nor Ci2i stockholder approvals are
required to consummate the transactions contemplated hereby. The execution and delivery of this Agreement by each OmniM2M and
Ci2i Stockholder which is not a natural person (“Entity Shareholder”) and the consummation of the transactions
contemplated hereby by each Entity Shareholder have been duly authorized by all necessary action by the Entity Shareholder and
no other proceedings on the part of OmniM2M or Ci2i or any OmniM2M or Ci2i Stockholder are necessary to authorize this Agreement
or to consummate the transactions contemplated hereby.

 

Section
3.5 No Conflict or Violation. The execution, delivery and performance of this Agreement by OmniM2M or Ci2i or any OmniM2M
or Ci2i Stockholder does not and will not violate or conflict with any provision of the constituent documents of OmniM2M or Ci2i,
and does not and will not violate any provision of law, or any order, judgment or decree of any court or other governmental or
regulatory authority, nor violate, result in a breach of or constitute (with due notice or lapse of time or both) a default under
or give to any other entity any right of termination, amendment, acceleration or cancellation of any contract, lease, loan agreement,
mortgage, security agreement, trust indenture or other agreement or instrument to which OmniM2M or Ci2i or any OmniM2M or Ci2i
Stockholder is a party or by which it is bound or to which any of its respective properties or assets is subject, nor result in
the creation or imposition of any lien, charge or encumbrance of any kind whatsoever upon any of the properties or assets of OmniM2M
or Ci2i or any OmniM2M or Ci2i Stockholder, nor result in the cancellation, modification, revocation or suspension of any of the
licenses, franchises, permits to which OmniM2M or Ci2i or any OmniM2M or Ci2i Stockholder is bound.

 

Section
3.6 Financial Statements. The financial statements of OminM2M and Ci2i for the years ended December 31, 2016 and 2015,
consisting of the audited balance sheets, statements of operations, statements of cash flows and statement of shareholders’
equity, including all related notes, fairly present in all material respects the financial position of each company as at the
respective dates thereof.

 

Section
3.7 Investment Representations.

 

a.
The TRAQIQ Shares will be acquired hereunder by each OmniM2M and Ci2i Stockholder solely for the account of such OmniM2M and Ci2i
Stockholder, for investment, and not with a view to the resale or distribution thereof, without prejudice, however, to each OmniM2M
or Ci2i Stockholders’ right at all times to sell or otherwise dispose of all or any part of such shares under the Securities
Act of 1933, as amended and other applicable federal and state securities laws. Each OmniM2M and Ci2i Stockholder understands
and is able to bear any economic risks associated with such OmniM2M or Ci2i Stockholders’ investment in the TRAQIQ Shares.
Each OmniM2M and Ci2i Stockholder has had full access to all the information it considers necessary or appropriate to make an
informed investment decision with respect to the TRAQIQ Shares to be acquired under this Agreement. Each OmniM2M and Ci2i Stockholder
further has had an opportunity to ask questions and receive answers from TRAQIQ’s management regarding TRAQIQ and to obtain
additional information (to the extent TRAQIQ’s management possessed such information or could acquire it without unreasonable
effort or expense) necessary to verify any information furnished to such OmniM2M or Ci2i Stockholder or to which the OmniM2M or
Ci2i Stockholder had access.

 

    	4

    	 

    

 

b.
OmniM2M and Ci2i Stockholder Status

 

(i)
Each OmniM2M and Ci2i Stockholder hereby agrees and acknowledges that it is “U.S. Person” (as defined below) at the
time the OmniM2M Stockholder was offered the TRAQIQ Shares and as of the date hereof. For the purpose of this Agreement, a “U.S.
Person” means:

 

(A)
Any natural person resident in the United States;

 

(B)
Any partnership or corporation organized or incorporated under the laws of the United States;

 

(C)
Any estate of which any executor or administrator is a U.S. person;

 

(D)
Any trust of which any trustee is a U.S. person;

 

(E)
Any agency or branch of a foreign entity located in the United States;

 

(F)
Any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit
or account of a U.S. person;

 

(G)
Any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated,
or (if an individual) resident of the United States; or

 

(H)
Any partnership or corporation if (i) organized or incorporated under the laws of any foreign jurisdiction and (ii) formed by
a U.S. person principally for the purpose of investing in securities not registered under the 1933 Act, unless it is organized
or incorporated, and owned, by accredited investor(s) (as defined in Rule 501(a) of Regulation D promulgated under the 1933 Act)
who are not natural persons, estates or trusts.

 

“United
States” or “U.S.” means the United States of America, its territories and possessions, any State of the United
States, and the District of Columbia.

 

(ii)
Each OmniM2M and Ci2i Stockholder understands that no action has been or will be taken in any jurisdiction by TRAQIQ that would
permit a public offering of the Shares in any country or jurisdiction where action for that purpose is required.

 

(iii)
Each OmniM2M Stockholder and Ci2i Stockholder (i) as of the date of this Agreement is located within the United States, and (ii)
is not purchasing the TRAQIQ Shares for the account or benefit of any non-U.S. Person, except in accordance with one or more available
exemptions from the registration requirements of the 1933 Act or in a transaction not subject thereto.

 

(iv)
Each OmniM2M Stockholder and Ci2i Stockholder agrees not resell the TRAQIQ Shares except in accordance with the provisions of
Regulation D, pursuant to a registration statement under the 1933 Act, or pursuant to an available exemption from registration;
and agrees not to engage in hedging transactions with regard to such securities unless in compliance with the 1933 Act.

 

(v)
Each OmniM2M Stockholder and Ci2i Stockholder agrees: (i) to not engage in hedging transactions with regard to shares of TRAQIQ
unless in compliance with the 1933 Act; and (ii) as applicable, to include statements in any documentation with regard to TRAQIQ
Shares to the effect that the securities have not been registered under the 1933 Act and may not be offered or sold in the United
States or to U.S. persons unless the securities are registered under the 1933 Act, or an exemption from the registration requirements
of the 1933 Act is available.

 

(vi)
No form of “directed selling efforts” (as defined under the 1933 Act), general solicitation or general advertising
in violation of the 1933 Act has been or will be used nor will any offers by means of any directed selling efforts in the United
States be made by any OmniM2M Stockholder or Ci2i Stockholder nor any of their representatives in connection with the offer and
sale of the TRAQIQ Shares.

 

    	5

    	 

    

 

c.
To the best knowledge of each OmniM2M Stockholder and Ci2i Stockholder, this Agreement and the transactions contemplated herein
are not part of a plan or scheme to evade the registration provisions of the Securities Act, and the TRAQIQ Shares are being acquired
by each OmniM2M Stockholder and Ci2i Stockholder for investment purposes.

 

d.
The OmniM2M Stockholder and Ci2i Stockholder hereby agree that the TRAQIQ Shares, upon issuance, shall bear the following or similar
legend:

 

“THE
SECURITIES REPRESENTED HEREBY HAVE BEEN OFFERED IN AN TRANSACTION TO A PERSON WHO IS A U.S. PERSON (AS DEFINED HEREIN) PURSUANT
TO REGULATION D UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “1933 ACT”). NONE OF THE SECURITIES
REPRESENTED HEREBY HAVE BEEN REGISTERED UNDER THE 1933 ACT, OR ANY U.S. STATE SECURITIES LAWS, AND, UNLESS SO REGISTERED, MAY
NOT BE OFFERED OR SOLD, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES (AS DEFINED HEREIN) OR TO U.S. PERSONS EXCEPT IN ACCORDANCE
WITH THE PROVISIONS OF REGULATION D UNDER THE 1933 ACT, PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE 1933 ACT, OR
PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE 1933 ACT AND
IN EACH CASE ONLY IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. IN ADDITION, HEDGING TRANSACTIONS INVOLVING THE SECURITIES
MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE 1933 ACT. “UNITED STATES” AND “U.S. PERSON” ARE AS
DEFINED BY REGULATION S UNDER THE 1933 ACT.”

 

Section
3.8 Brokers’ Fees. No OmniM2M Stockholder nor Ci2i Stockholder has any liability to pay any fees or commissions
or other consideration to any broker, finder, or agent with respect to the transactions contemplated by this Agreement.

 

ARTICLE
IV

COVENANTS

 

Section
4.1 Consents and Approvals. Without limitation of the foregoing, the parties shall:

 

a.
use their reasonable commercial efforts to obtain all necessary consents, waivers, authorizations and approvals of all governmental
and regulatory authorities, domestic and foreign, and of all other persons, firms or corporations required in connection with
the execution, delivery and performance by them of this Agreement; and

 

b.
diligently assist and cooperate with each party in preparing and filing all documents required to be submitted by a party to any
governmental or regulatory authority, domestic or foreign, in connection with such transactions and in obtaining any governmental
consents, waivers, authorizations or approvals which may be required to be obtained connection in with such transactions.

 

Section
4.2 Stock Issuance. From and after the date of this Agreement until the Closing Date, neither TRAQIQ nor OmniM2M nor
Ci2i shall issue any additional shares of their capital stock.

 

Section
4.3 Post-closing Stock Issuance. After the Closing Date, TRAQIQ shall issue the shares as set forth in Schedule
4.3.

 

Section
4.4 Registration of Shares. Promptly after the Closing Date, the Shareholders and management of TRAQIQ shall cause
TRAQIQ to file with the Securities and Exchange Commission a registration statement under the Securities Act to register for sale
to the public such number of authorized but unissued shares of TRAQIQ common stock as set forth in Schedule 4.3. Such registration
statement shall also include all previously issued TRAQIQ shares and may include such other shares as TRAQIQ determines. TRAQIQ
shall use their best efforts to cause such registration statement to be declared effective by the Securities and Exchange Commission
as soon as practicable after the of Closing Date.

 

    	6

    	 

    

 

ARTICLE
V

CONDITIONS
TO OBLIGATIONS OF OMNIM2M AND THE OMNIM2M STOCKHOLDERS AND

CI2I
AND THE CI2I STOCKHOLDERS

 

The
obligations of OmniM2M and Ci2i and each OmniM2M and Ci2i Stockholder to consummate the transactions contemplated by this Agreement
are subject to the fulfillment, at or before the Closing Date, of the following conditions, any one or more of which may be waived
by both OmniM2M and Ci2i and each OmniM2M and Ci2i Stockholder in their sole discretion:

 

Section
5.1 Representations and Warranties of TRAQIQ. All representations and warranties made by TRAQIQ in this Agreement shall
be true and correct on and as of the Closing Date as if again made by TRAQIQ as of such date.

 

Section
5.2 Agreements and Covenants. TRAQIQ shall have performed and complied in all material respects to all agreements and
covenants required by this Agreement to be performed or complied with by it on or prior to the Closing Date.

 

Section
5.3 Consents and Approvals. Consents, waivers, authorizations and approvals of any governmental or regulatory authority,
domestic or foreign, and of any other person, firm or corporation, required in connection with the execution, delivery and performance
of this Agreement shall be in full force and effect on the Closing Date.

 

Section
5.4 No Violation of Orders. No preliminary or permanent injunction or other order issued by any court or governmental
or regulatory authority, domestic or foreign, nor any statute, rule, regulation, decree or executive order promulgated or enacted
by any government or governmental or regulatory authority, which declares this Agreement invalid in any respect or prevents the
consummation of the transactions contemplated hereby, or which materially and adversely affects the assets, properties, operations,
prospects, net income or financial condition of TRAQIQ shall be in effect; and no action or proceeding before any court or governmental
or regulatory authority, domestic or foreign, shall have been instituted or threatened by any government or governmental or regulatory
authority, domestic or foreign, or by any other person, or entity which seeks to prevent or delay the consummation of the transactions
contemplated by this Agreement or which challenges the validity or enforceability of this Agreement.

 

Section
5.5 Other Closing Documents. OmniM2M and Ci2i shall have received such other certificates, instruments and documents
in confirmation of the representations and warranties of TRAQIQ or in furtherance of the transactions contemplated by this Agreement
as OmniM2M and Ci2i or their counsel may reasonably request.

 

ARTICLE
VI

CONDITIONS
TO OBLIGATIONS OF TRAQIQ

 

The
obligations of TRAQIQ to consummate the transactions contemplated by this Agreement are subject to the fulfillment, at or before
the Closing Date, of the following conditions, any one or more of which may be waived by TRAQIQ in its sole discretion:

 

Section
6.1 Representations and Warranties of OmniM2M and Ci2i. All representations and warranties made by OmniM2M and Ci2i
in this Agreement shall be true and correct on and as of the Closing Date as if again made by OmniM2M and Ci2i on and as of such
date.

 

Section
6.2 Agreements and Covenants. OmniM2M and Ci2i shall have performed and complied in all material respects to all agreements
and covenants required by this Agreement to be performed or complied with by it on or prior to the Closing Date.

 

    	7

    	 

    

 

Section
6.3 Consents and Approvals. All consents, waivers, authorizations and approvals of any governmental or regulatory authority,
domestic or foreign, and of any other person, firm or corporation, required in connection with the execution, delivery and performance
of this Agreement, shall have been duly obtained and shall be in full force and effect on the Closing Date.

 

Section
6.4 No Violation of Orders. No preliminary or permanent injunction or other order issued by any court or other
governmental or regulatory authority, domestic or foreign, nor any statute, rule, regulation, decree or executive order
promulgated or enacted by any government or governmental or regulatory authority, domestic or foreign, that declares this
Agreement invalid or unenforceable in any respect or which prevents the consummation of the transactions contemplated hereby,
or which materially and adversely affects the assets, properties, operations, prospects, net income or financial condition of
OmniM2M or Ci2i, taken as a whole, shall be in effect; and no action or proceeding before any court or government or
regulatory authority, domestic or foreign, shall have been instituted or threatened by any government or governmental or
regulatory authority, domestic or foreign, or by any other person, or entity which seeks to prevent or delay the consummation
of the transactions contemplated by this Agreement or which challenges the validity or enforceability of this
Agreement.

 

Section
6.5 Other Closing Documents. TRAQIQ shall have received such other certificates, instruments and documents in confirmation
of the representations and warranties of OmniM2M and Ci2i or in furtherance of the transactions contemplated by this Agreement
as TRAQIQ or its counsel may reasonably request.

 

ARTICLE
VII

TERMINATION
AND ABANDONMENT

 

Section
7.1 Methods of Termination. This Agreement may be terminated and the transactions contemplated hereby may be abandoned
at any time before July 19, 2017 by notice of one party to the others.

 

ARTICLE
VIII

MISCELLANEOUS
PROVISIONS

 

Section
8.1 Survival of Provisions. The respective representations, warranties, covenants and agreements of each of the parties
to this Agreement (except covenants and agreements which are expressly required to be performed and are performed in full on or
before the Closing Date) shall survive the Closing Date and the consummation of the transactions contemplated by this Agreement.
In the event of a breach of any of such representations, warranties or covenants, the party to whom such representations, warranties
or covenants have been made shall have all rights and remedies for such breach available to it under the provisions of this Agreement
or otherwise, whether at law or in equity, regardless of any disclosure to, or investigation made by or on behalf of such party
on or before the Closing Date.

 

Section
8.2 Publicity. No party shall cause the publication of any press release or other announcement with respect to this
Agreement or the transactions contemplated hereby without the consent of the other parties, unless a press release or announcement
is required by law. If any such announcement or other disclosure is required by law, the disclosing party agrees to give the non-disclosing
parties prior notice and an opportunity to comment on the proposed disclosure.

 

Section
8.3 Successors and Assigns. This Agreement shall inure to the benefit of, and be binding upon, the parties hereto and
their respective successors and assigns; provided, however, that no party shall assign or delegate any of the obligations created
under this Agreement without the prior written consent of the other parties.

 

Section
8.4 Fees and Expenses. Except as otherwise expressly provided in this Agreement, all legal and other fees, costs and
expenses incurred in connection with this Agreement and the transactions contemplated hereby shall be paid by the party incurring
such fees, costs or expenses.

 

Section
8.5 Notices. All notices and other communications given or made pursuant hereto shall be in writing and shall be deemed
to have been given or made if in writing and delivered personally or sent by registered or certified mail (postage prepaid, return
receipt requested) to the parties at the following addresses:

 

    	8

    	 

    

 

If
to OmniM2M or the Omni Stockholders or to Ci2i or the Ci2i Stockholders, to:

 

OmniM2M,
Inc. or Ci2i Services, Inc.

14205
SE 36th Street, Suite 100

Bellevue,
WA 98006

Attention:
Ajay Sikka

Fax:
(425) 818-0560

E-mail:
ajay@traqiq.com

 

If
to TRAQIQ, to:

 

TraqIQ,
Inc.

201
Santa Monica Blvd., Suite 300

Santa
Monica, CA 90401-2224

Attention:
Gary L. Blum, CEO

Fax:
(310) 388-5899

E-mail:
gblum@gblumlaw.com

 

With
a copy to:

 

Hateley
& Hampton

201
Santa Monica Blvd., Suite 300

Santa
Monica, CA 90401-2224

Attention:
Donald P. Hateley, Esq., CPA

Fax:
(310) 388-5899

E-mail:
dhateley@hateleyhampton.com

 

or
to such other persons or at such other addresses as shall be furnished by any party by like notice to the others, and such notice
or communication shall be deemed to have been given or made as of the date so delivered or mailed.

 

Section
8.6 Entire Agreement. This Agreement, together with the exhibits hereto, represents the entire agreement and understanding
of the parties with reference to the transactions set forth herein and no representations or warranties have been made in connection
with this Agreement other than those expressly set forth herein or in the exhibits, certificates and other documents delivered
in accordance herewith. This Agreement supersedes all prior negotiations, discussions, correspondence, communications, understandings
and agreements between the parties relating to the subject matter of this Agreement and all prior drafts of this Agreement, all
of which are merged into this Agreement. No prior drafts of this Agreement and no words or phrases from any such prior drafts
shall be admissible into evidence in any action or suit involving this Agreement.

 

Section
8.7 Severability. This Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision
hereof shall not affect the validity or enforceability of this Agreement or of any other term or provision hereof. Furthermore,
in lieu of any such invalid or unenforceable term or provision, the parties hereto intend that there shall be added as a part
of this Agreement a provision as similar in terms to such invalid or unenforceable provision as may be possible so as to be valid
and enforceable.

 

Section
8.8 Titles and Headings. The Article and Section headings contained in this Agreement are solely for convenience of
reference and shall not affect the meaning or interpretation of this Agreement or of any term or provision hereof.

 

Section
8.9 Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original
and all of which together shall be considered one and the same agreement.

 

    	9

    	 

    

 

Section
8.10 Convenience of Forum; Consent to Jurisdiction. The parties to this Agreement, acting for themselves and for their
respective successors and assigns, without regard to domicile, citizenship or residence, hereby expressly and irrevocably elect
as the sole judicial forum for the adjudication of any matters arising under or in connection with this Agreement, and consent
and subject themselves to the jurisdiction of, the courts of the State of California, County of Los Angeles, and/or the United
States District Court for the Central District of California, in respect of any matter arising under this Agreement. Service of
process, notices and demands of such courts may be made upon any party to this Agreement by personal service at any place where
it may be found or giving notice to such party as provided in Section 8.5.

 

Section
8.11 Enforcement of the Agreement. The parties hereto agree that irreparable damage would occur if any of the provisions
of this Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed
that the parties shall be entitled to an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically
the terms and provisions hereto, this being in addition to any other remedy to which they are entitled at law or in equity.

 

Section
8.12 Governing Law; Jurisdiction; Venue. This Agreement shall be governed by and interpreted and enforced in accordance
with the laws of the State of California without giving effect to the choice of law provisions thereof.

 

Section
8.13 Amendments and Waivers. No amendment of any provision of this Agreement shall be valid unless the same shall be
in writing and signed by all of the parties hereto. No waiver by any party of any default, misrepresentation, or breach of warranty
or covenant hereunder, whether intentional or not, shall be deemed to extend to any prior or subsequent default, misrepresentation,
or breach of warranty or covenant hereunder or affect in any way any rights arising by virtue of any prior or subsequent such
occurrence.

 

[Signatures’
Pages Follow]

 

    	10

    	 

    

 

IN
WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first above written.

 

TRAQIQ,
INC. 

  

	By:	/s/
    Gary L. Blum	 
	 	Gary
    L. Blum	 
	Its:	Chief
    Executive Officer	 

 

OmniM2M,
Inc. 

 

	By:
    	/s/
Ajay Sikka	 
	 	Ajay
    Sikka	 
	Its:	Chief
    Executive Officer	 

 

Ci2i
Services, Inc. 

 

	By:
    	/s/
Ajay Sikka	 
	 	Ajay
    Sikka	 
	Its:	Chief
    Executive Officer	 

 

[OminM2M
signatures on next page]

 

    	11

    	 

    

 

OMNIM2M,
INC. STOCKHOLDERS

 

	By:	 	 	By:	 
	 	Ajay
    Sikka	 	 	Krishnan
    Thyagarajan
	 	 	 	 	 
	By:	 	 	By:	 
	 	Sandeep
    Soni	 	 	La
    Suprama (Sunil Shah)
	 	 	 	 	 
	By:		 	By:	 
	 	Shital
    Doshi-Shah LLC	 		Ashish
    Pandey
	Its:	Manager/Member	 	 	
	 	 	 	 	 
	By:		 	By:	 
	 	Karan
    Khana	 	 	James
    G. W. Reed
	 	 	 	 	 
	By:	 	 	By:	 
	 	Rajnish
    Mishra	 	 	Beverly
    Reed
	 	 	 	 	 
	By:	 	 	By:	 
	 	Michael
    Stevens	 	 	Bo
    Industries LLC
	 	 	 	Its:	 Manager/Member
	 	 	 	 	 
	By:	 	 	By:	 
	 	W
    & W Group LLC	 	 	Walter
    Boris Benadof
	Its:	Manager/Member	 		
	 	 	 	 	 
	By:	 	 	By:	 
	 	Dan
    Clem	 	 	Satinder
    Thiara
	 	 	 	 	 
	By:	 	 	By:	 
	 	Prakash
    Sundaresan	 	 	Sin
    Lew

 

[Ci2i
signatures on next page]

 

    	12

    	 

    

 

Ci2I
SERVICES, INC. STOCKHOLDERS

 

	By:
    	 	 
	 	 Ajay
    Sikka	 

 

	By:
    	 	 
	 	 DV
    Sikka	 

 

	By:
    	 	 
	 	 Virandra
    Sikka	 

 

    	13

    	 

    

 

EXHIBIT
A

OMNIM2M
STOCKHOLDERS

 

	OmniM2M shareholders	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	OmniM2M shares	 	 	%	 	 	New TraqIQ shares	 	 	% of TraqIQ	 
	 	 	 	 	 	 	 	 	 	 	 	 	 
	Ajay Sikka	 	 	1,019,070	 	 	 	68.7	%	 	 	2,060,591	 	 	 	22.1	%
	Krishnan Thyagarajan	 	 	100,000	 	 	 	6.7	%	 	 	202,203	 	 	 	2.2	%
	Sandeep Soni	 	 	8,000	 	 	 	0.5	%	 	 	16,176	 	 	 	0.2	%
	La Suprama (Sunil Shah)	 	 	14,535	 	 	 	1.0	%	 	 	29,390	 	 	 	0.3	%
	Shital Doshi-Shah LLC	 	 	29,651	 	 	 	2.0	%	 	 	59,956	 	 	 	0.6	%
	Ashish Pandey	 	 	5,814	 	 	 	0.4	%	 	 	11,756	 	 	 	0.1	%
	Karan Khanna	 	 	8,721	 	 	 	0.6	%	 	 	17,634	 	 	 	0.2	%
	James G W Reed & Beverly Reed	 	 	43,605	 	 	 	2.9	%	 	 	88,170	 	 	 	0.9	%
	Vinay Gupta	 	 	13,061	 	 	 	0.9	%	 	 	26,410	 	 	 	0.3	%
	Mukund Ghangurde	 	 	13,061	 	 	 	0.9	%	 	 	26,410	 	 	 	0.3	%
	James G W Reed & Beverly Reed	 	 	52,244	 	 	 	3.5	%	 	 	105,639	 	 	 	1.1	%
	Rajnish Mishra	 	 	13,061	 	 	 	0.9	%	 	 	26,410	 	 	 	0.3	%
	Michael Stevens	 	 	13,061	 	 	 	0.9	%	 	 	26,410	 	 	 	0.3	%
	Bo Industries, LLC	 	 	39,184	 	 	 	2.6	%	 	 	79,231	 	 	 	0.9	%
	W & W Group LLC (Jian Wu)	 	 	26,122	 	 	 	1.8	%	 	 	52,820	 	 	 	0.6	%
	Walter Boris Benadof	 	 	13,061	 	 	 	0.9	%	 	 	26,410	 	 	 	0.3	%
	Dan Clem (vested)	 	 	875	 	 	 	0.1	%	 	 	1,769	 	 	 	0.0	%
	Satinder Thiara	 	 	52,244	 	 	 	3.5	%	 	 	105,639	 	 	 	1.1	%
	Shital Doshi-Shah LLC	 	 	5,225	 	 	 	0.4	%	 	 	10,565	 	 	 	0.1	%
	Prakash Sundaresan	 	 	5,225	 	 	 	0.4	%	 	 	10,565	 	 	 	0.1	%
	Sin Lew	 	 	7,837	 	 	 	0.5	%	 	 	15,847	 	 	 	0.2	%
	 	 	 	1,483,657	 	 	 	100.0	%	 	 	3,000,000	 	 	 	32.20	%

 

    	14

    	 

    

 

EXHIBIT
B

Ci2i
SERVICES STOCKHOLDERS

 

	Ci2i shareholders	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	Ci2i shares	 	 	%	 	 	New TraqIQ shares	 	 	% of TraqIQ	 
	Ajay Sikka	 	 	9,594,403	 	 	 	57.6	%	 	 	1,728,005	 	 	 	18.6	%
	DV Sikka	 	 	2,531,250	 	 	 	15.2	%	 	 	455,892	 	 	 	4.9	%
	Virandra Sikka	 	 	4,531,250	 	 	 	27.2	%	 	 	816,103	 	 	 	8.8	%
	 	 	 	16,656,903	 	 	 	100.0	%	 	 	3,000,000	 	 	 	32.2	%

 

 

 

    	15

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00274-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00274-of-00352.parquet"}]]